Characteristics and conditioning regimens for patients who underwent HDT/ASCT
| Characteristic . | No. patients (%) . |
|---|---|
| Response to ICE | |
| ICE-chemosensitive | 38/43 (88.4) |
| ICE-failure | 4/42 (9.5) |
| Conditioning regimen | |
| BEAM | 11 |
| Cyclophosphamide/etoposide/TBI | 11 |
| Ifosfamide/etoposide/TBI | 11 |
| CBV | 7 |
| High-dose ICE | 2 |
| Hyperfractionated involved-field radiotherapy | 26/42 (61.9) |
| Characteristic . | No. patients (%) . |
|---|---|
| Response to ICE | |
| ICE-chemosensitive | 38/43 (88.4) |
| ICE-failure | 4/42 (9.5) |
| Conditioning regimen | |
| BEAM | 11 |
| Cyclophosphamide/etoposide/TBI | 11 |
| Ifosfamide/etoposide/TBI | 11 |
| CBV | 7 |
| High-dose ICE | 2 |
| Hyperfractionated involved-field radiotherapy | 26/42 (61.9) |